Cargando…

Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy

Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad range of Th1, Th2 and Th17 cytokines in the serum of IgAN patients. We searched for significant c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Keiko, Sugiyama, Hitoshi, Morinaga, Hiroshi, Kitagawa, Masashi, Kano, Yuzuki, Onishi, Yasuhiro, Mise, Koki, Tanabe, Katsuyuki, Uchida, Haruhito A., Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004527/
https://www.ncbi.nlm.nih.gov/pubmed/36902810
http://dx.doi.org/10.3390/jcm12052023
_version_ 1784904855368761344
author Tanaka, Keiko
Sugiyama, Hitoshi
Morinaga, Hiroshi
Kitagawa, Masashi
Kano, Yuzuki
Onishi, Yasuhiro
Mise, Koki
Tanabe, Katsuyuki
Uchida, Haruhito A.
Wada, Jun
author_facet Tanaka, Keiko
Sugiyama, Hitoshi
Morinaga, Hiroshi
Kitagawa, Masashi
Kano, Yuzuki
Onishi, Yasuhiro
Mise, Koki
Tanabe, Katsuyuki
Uchida, Haruhito A.
Wada, Jun
author_sort Tanaka, Keiko
collection PubMed
description Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad range of Th1, Th2 and Th17 cytokines in the serum of IgAN patients. We searched for significant cytokines, which were associated with clinical parameters and histological scores in IgAN patients. Results: Among 15 cytokines, the levels of soluble CD40L (sCD40L) and IL-31 were higher in IgAN patients and were significantly associated with a higher estimated glomerular filtration rate (eGFR), a lower urinary protein to creatinine ratio (UPCR), and milder tubulointerstitial lesions (i.e., the early phase of IgAN). Multivariate analysis revealed that serum sCD40L was an independent determinant of a lower UPCR after adjustment for age, eGFR, and mean blood pressure (MBP). CD40, a receptor of sCD40L, has been reported to be upregulated on mesangial cells in IgAN. The sCD40L/CD40 interaction may directly induce inflammation in mesangial areas and may therefore be involved in the development of IgAN. Conclusions: The present study demonstrated the significance of serum sCD40L and IL-31 in the early phase of IgAN. Serum sCD40L may be a marker of the beginning of inflammation in IgAN.
format Online
Article
Text
id pubmed-10004527
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100045272023-03-11 Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy Tanaka, Keiko Sugiyama, Hitoshi Morinaga, Hiroshi Kitagawa, Masashi Kano, Yuzuki Onishi, Yasuhiro Mise, Koki Tanabe, Katsuyuki Uchida, Haruhito A. Wada, Jun J Clin Med Article Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad range of Th1, Th2 and Th17 cytokines in the serum of IgAN patients. We searched for significant cytokines, which were associated with clinical parameters and histological scores in IgAN patients. Results: Among 15 cytokines, the levels of soluble CD40L (sCD40L) and IL-31 were higher in IgAN patients and were significantly associated with a higher estimated glomerular filtration rate (eGFR), a lower urinary protein to creatinine ratio (UPCR), and milder tubulointerstitial lesions (i.e., the early phase of IgAN). Multivariate analysis revealed that serum sCD40L was an independent determinant of a lower UPCR after adjustment for age, eGFR, and mean blood pressure (MBP). CD40, a receptor of sCD40L, has been reported to be upregulated on mesangial cells in IgAN. The sCD40L/CD40 interaction may directly induce inflammation in mesangial areas and may therefore be involved in the development of IgAN. Conclusions: The present study demonstrated the significance of serum sCD40L and IL-31 in the early phase of IgAN. Serum sCD40L may be a marker of the beginning of inflammation in IgAN. MDPI 2023-03-03 /pmc/articles/PMC10004527/ /pubmed/36902810 http://dx.doi.org/10.3390/jcm12052023 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tanaka, Keiko
Sugiyama, Hitoshi
Morinaga, Hiroshi
Kitagawa, Masashi
Kano, Yuzuki
Onishi, Yasuhiro
Mise, Koki
Tanabe, Katsuyuki
Uchida, Haruhito A.
Wada, Jun
Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
title Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
title_full Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
title_fullStr Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
title_full_unstemmed Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
title_short Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
title_sort serum scd40l and il-31 in association with early phase of iga nephropathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004527/
https://www.ncbi.nlm.nih.gov/pubmed/36902810
http://dx.doi.org/10.3390/jcm12052023
work_keys_str_mv AT tanakakeiko serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT sugiyamahitoshi serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT morinagahiroshi serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT kitagawamasashi serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT kanoyuzuki serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT onishiyasuhiro serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT misekoki serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT tanabekatsuyuki serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT uchidaharuhitoa serumscd40landil31inassociationwithearlyphaseofiganephropathy
AT wadajun serumscd40landil31inassociationwithearlyphaseofiganephropathy